Efficacy of 177Lu-Dotatate Induction and Maintenance Therapy of Various Types of Neuroendocrine Tumors: A Phase II Registry Study
Sistani, Golmehr, Sutherland, Duncan E. K., Mujoomdar, Amol, Wiseman, Daniele P., Khatami, Alireza, Tsvetkova, Elena, Reid, Robert H., Laidley, David T.
Published in Current oncology (Toronto) (21.12.2020)
Published in Current oncology (Toronto) (21.12.2020)
Get full text
Journal Article
Survival predictors of 177Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS)
Swiha, Mina M., Sutherland, Duncan E. K., Sistani, Golmehr, Khatami, Alireza, Abazid, Rami M., Mujoomdar, Amol, Wiseman, Daniele P., Romsa, Jonathan G., Reid, Robert H., Laidley, David T.
Published in Journal of cancer research and clinical oncology (01.01.2022)
Published in Journal of cancer research and clinical oncology (01.01.2022)
Get full text
Journal Article
Survival predictors of 177 Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS)
Swiha, Mina M, Sutherland, Duncan E K, Sistani, Golmehr, Khatami, Alireza, Abazid, Rami M, Mujoomdar, Amol, Wiseman, Daniele P, Romsa, Jonathan G, Reid, Robert H, Laidley, David T
Published in Journal of cancer research and clinical oncology (01.01.2022)
Get full text
Published in Journal of cancer research and clinical oncology (01.01.2022)
Journal Article
Efficacy of 177 Lu-Dotatate Induction and Maintenance Therapy of Various Types of Neuroendocrine Tumors: A Phase II Registry Study
Sistani, Golmehr, Sutherland, Duncan E K, Mujoomdar, Amol, Wiseman, Daniele P, Khatami, Alireza, Tsvetkova, Elena, Reid, Robert H, Laidley, David T
Published in Current oncology (Toronto) (21.12.2020)
Get full text
Published in Current oncology (Toronto) (21.12.2020)
Journal Article